Lazard Asset Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,730	Closed	-$43K	–	2254
2024 Q2	$43K	Sell	1,730 -5,373	-76%	-$139K	﹤0.01%	1951
2024 Q1	$180K	Buy	+7,103	New	+$172K	﹤0.01%	1336
2023 Q4	–	Sell	-7,909	Closed	-$147K	–	2243
2023 Q3	$147K	Buy	+7,909	New	+$164K	﹤0.01%	1489
2023 Q1	–	Sell	-2,651	Closed	-$78K	–	2283
2022 Q4	$78K	Hold	2,651	–	–	﹤0.01%	1616
2022 Q3	$63K	Hold	2,651	–	–	﹤0.01%	1687
2022 Q2	$59K	Buy	+2,651	New	+$59.1K	﹤0.01%	1734
2022 Q1	–	Sell	-1,277	Closed	-$45K	–	2319
2021 Q4	$45K	Hold	1,277	–	–	﹤0.01%	1780
2021 Q3	$54K	Buy	+1,277	New	+$52.6K	﹤0.01%	1644
2021 Q2	–	Sell	-1,791	Closed	-$73K	–	1951
2021 Q1	$73K	Sell	1,791 -331	-16%	-$12.6K	﹤0.01%	1284
2020 Q4	$96K	Sell	2,122 -36	-2%	-$1.37K	﹤0.01%	1191
2020 Q3	$76K	Hold	2,158	–	–	﹤0.01%	1070
2020 Q2	$81K	Buy	2,158 +302	+16%	+$9.95K	﹤0.01%	1069
2020 Q1	$53K	Buy	+1,856	New	+$75.1K	﹤0.01%	1152